Scientific article

Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis

Published inJournal of thrombosis and haemostasis, vol. 6, no. 3, p. 444-450
Publication date2008

BACKGROUND: PFA-100 is a point-of-care assay that evaluates platelet reactivity in high-shear-stress conditions by measuring the closure time (CT) of a membrane aperture. When determined with a collagen/epinephrine cartridge (CEPI), the CT is usually prolonged by aspirin. Studies of the predictive value of a short PFA-100CT(CEPI) for ischemic events in aspirin-treated patients have given variable results. OBJECTIVES: To conduct a systematic review and meta-analysis of studies on the clinical predictive value of a short PFA-100CT(CEPI) in aspirin-treated cardiovascular patients. PATIENTS AND METHODS: Relevant studies were identified by scanning electronic databases. Studies were selected if they included aspirin-treated patients with symptomatic atherosclerosis, measured the PFA-100CT(CEPI), used a CT cut-off value to define aspirin 'responders' and 'non-responders', and reported ischemic events. RESULTS: We selected seven non-prospective studies (1466 patients) and eight prospective studies (1227 patients). In non-prospective studies, the PFA-100CT(CEPI) was performed after the ischemic clinical endpoint, and a publication bias was identified. In prospective studies, the global odds ratio (OR) for the recurrence of an ischemic event in 'aspirin non-responders' relative to 'aspirin responders' was 2.1 [95% confidence interval (CI) 1.4-3.4, P < 0.001]. Pooled analysis with a random effect model revealed no heterogeneity (Q Cochran P = 0.36 and I(2) = 9.4%). CONCLUSIONS: A short PFA-100CT(CEPI) is associated with increased recurrence of ischemic events in aspirin-treated cardiovascular patients. This finding needs to be confirmed in stable ischemic patients, and the PFA-100CT(CEPI) cut-off needs to be refined in these patients.

  • Anti-Inflammatory Agents, Non-Steroidal/pharmacology
  • Aspirin/pharmacology
  • Blood Platelets/cytology
  • Cardiology/methods
  • Clinical Trials as Topic
  • Humans
  • Myocardial Ischemia
  • Platelet Activation
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors/pharmacology
  • Predictive Value of Tests
  • Prospective Studies
  • Time Factors
Citation (ISO format)
RENY, Jean-Luc et al. Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. In: Journal of thrombosis and haemostasis, 2008, vol. 6, n° 3, p. 444–450. doi: 10.1111/j.1538-7836.2008.02897.x
Main files (1)
Article (Accepted version)
ISSN of the journal1538-7836

Technical informations

Creation06/10/2009 8:11:00 AM
First validation06/10/2009 8:11:00 AM
Update time03/14/2023 3:06:23 PM
Status update03/14/2023 3:06:23 PM
Last indexation10/18/2023 10:32:07 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack